Prof. Valeria Santini, MD, an expert on MDS from the University of Florence, describes how the specific
genetic mutations you have can tell your doctor how likely your
MDS is to transform into leukemia and how the disease will probably respond to treatment. Along with platelet count and white blood cell count,
gene mutations and
chromosome abnormalities help your doctor understand whether your MDS is
high or
low risk and to make treatment decisions.
-
Share with family and friends:
Click here to take our SURVEY
Your feedback is important to us! We will use your feedback to develop future areas of content about MDS which will help other patients, caregivers and families.